These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 12829159)
1. Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. Dikomey E; Borgmann K; Peacock J; Jung H Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1194-200. PubMed ID: 12829159 [TBL] [Abstract][Full Text] [Related]
2. The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules. Burnet NG; Nyman J; Turesson I; Wurm R; Yarnold JR; Peacock JH Radiother Oncol; 1994 Dec; 33(3):228-38. PubMed ID: 7716263 [TBL] [Abstract][Full Text] [Related]
3. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Hoeller U; Borgmann K; Bonacker M; Kuhlmey A; Bajrovic A; Jung H; Alberti W; Dikomey E Radiother Oncol; 2003 Nov; 69(2):137-44. PubMed ID: 14643950 [TBL] [Abstract][Full Text] [Related]
4. Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes. Dunst J; Neubauer S; Becker A; Gebhart E Strahlenther Onkol; 1998 Oct; 174(10):510-6. PubMed ID: 9810318 [TBL] [Abstract][Full Text] [Related]
5. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Geara FB; Peters LJ; Ang KK; Wike JL; Brock WA Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1173-9. PubMed ID: 8262844 [TBL] [Abstract][Full Text] [Related]
6. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study. Vandevoorde C; Depuydt J; Veldeman L; De Neve W; Sebastià N; Wieme G; Baert A; De Langhe S; Philippé J; Thierens H; Vral A Int J Radiat Biol; 2016 Dec; 92(12):823-836. PubMed ID: 27586010 [TBL] [Abstract][Full Text] [Related]
7. Normal tissue radiosensitivity in breast cancer patients. Ramsay J; Birrell G Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):339-44. PubMed ID: 7836087 [TBL] [Abstract][Full Text] [Related]
8. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability. Mackay RI; Hendry JH Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559 [TBL] [Abstract][Full Text] [Related]
9. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy. Borgmann K; Hoeller U; Nowack S; Bernhard M; Röper B; Brackrock S; Petersen C; Szymczak S; Ziegler A; Feyer P; Alberti W; Dikomey E Int J Radiat Oncol Biol Phys; 2008 May; 71(1):256-64. PubMed ID: 18406889 [TBL] [Abstract][Full Text] [Related]
10. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?]. Dunst J; Gebhart E; Neubauer S Strahlenther Onkol; 1995 Oct; 171(10):581-6. PubMed ID: 8571177 [TBL] [Abstract][Full Text] [Related]
11. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Johansen J; Bentzen SM; Overgaard J; Overgaard M Radiother Oncol; 1996 Aug; 40(2):101-9. PubMed ID: 8884963 [TBL] [Abstract][Full Text] [Related]
13. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. Bentzen SM; Overgaard M; Overgaard J Eur J Cancer; 1993; 29A(10):1373-6. PubMed ID: 8398261 [TBL] [Abstract][Full Text] [Related]
14. Correlation between normal tissue complications and in vitro radiosensitivity of skin fibroblasts derived from radiotherapy patients treated for variety of tumors. Alsbeih G; Malone S; Lochrin C; Girard A; Fertil B; Raaphorst GP Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):143-52. PubMed ID: 10656386 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the radiosensitivity of normal-tissue cells with normal-tissue reactions after radiotherapy. Slonina D; Klimek M; Szpytma T; Gasinska A Int J Radiat Biol; 2000 Sep; 76(9):1255-64. PubMed ID: 10993636 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Brock WA; Tucker SL; Geara FB; Turesson I; Wike J; Nyman J; Peters LJ Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1371-9. PubMed ID: 7635777 [TBL] [Abstract][Full Text] [Related]
17. Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy. Pinar B; Lara PC; Lloret M; Bordón E; Núñez MI; Villalobos M; Guerrero R; Luna JD; Ruiz de Almodóvar JM Radiat Res; 2007 Oct; 168(4):415-22. PubMed ID: 17903032 [TBL] [Abstract][Full Text] [Related]
18. Can 8-oxo-dG be used as a predictor for individual radiosensitivity? Haghdoost S; Svoboda P; Näslund I; Harms-Ringdahl M; Tilikides A; Skog S Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):405-10. PubMed ID: 11380227 [TBL] [Abstract][Full Text] [Related]
19. Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy. Henríquez-Hernández LA; Carmona-Vigo R; Pinar B; Bordón E; Lloret M; Núñez MI; Rodríguez-Gallego C; Lara PC Radiat Oncol; 2011 Jun; 6():60. PubMed ID: 21645372 [TBL] [Abstract][Full Text] [Related]